Nuvation Bio Inc. (NUVB) Stock

Nuvation Bio Inc. (NUVB) is a Healthcare stock trading at $5.54 (as of 2026-06-18), with a market capitalization of $1.66B and a trailing P/E of -11.1. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Nuvation Bio Inc. is a clinical-stage biopharmaceutical company developing therapeutic candidates in oncology, including small-molecule programs such as NUV-422 and other drug candidates targeting pathways involved in tumor growth and DNA damage response. It also develops a drug-drug conjugate platform using PARP inhibitor-based warheads for anti-cancer applications.

Valuation — source: SEC EDGAR (first-party)
Price$5.54
Market Cap$1.66B
P/E Ratio-11.1
EV / EBITDA-10.7
Price / Book5.21
Price / Sales11.64
DCF Value (model)$-8.41
DCF Upside vs Price-251.8%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$62.90M
Net Margin-325.3%
Return on Equity-45.7%
Debt / Equity0.17
Current Ratio7.44
Revenue Growth (YoY)699.0%
EPS Growth (YoY)-71.6%
Financial Health — source: SEC EDGAR
Altman Z-Score1.17 (distress)
Valuation vs Sector & Industry
Stock P/E-11.1
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector-153.0%
vs Industry-164.4%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderFMR LLC ($223.04M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEODavid T. Hung
Employees273
CountryUS
IPO Date2020-08-26

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • Dyne Therapeutics, Inc. (DYN)
  • IDEAYA Biosciences, Inc. (IDYA)
  • Disc Medicine, Inc. (IRON)
  • Arcus Biosciences, Inc. (RCUS)
  • Mineralys Therapeutics, Inc. (MLYS)
  • Prestige Consumer Healthcare Inc. (PBH)
  • Catalyst Pharmaceuticals, Inc. (CPRX)
  • Supernus Pharmaceuticals, Inc. (SUPN)
NUVB earnings history · NUVB institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.